Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial

NCT02162966 is registered in ClinicalTrials.gov with King Saud Medical City as lead sponsor.

NCT NCT02162966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial
Lead sponsor
King Saud Medical City
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2014
Completion date
October 31, 2016
Enrollment
330 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infectious diseases